Actuate Therapeutics (ACTU) Stock Chart & Stock Price History $7.31 -0.88 (-10.74%) (As of 09/20/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsTrends Actuate Therapeutics Stock Price Performance5 Day Performance-8.74%1 Month Performance-13.59% Receive ACTU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Actuate Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Unstoppable ProsperityMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a row! But – knowing what the options trading landscape looks like, and what you're up against is a must.So make sure you claim your free seat by clicking here now. ACTU Stock Chart for Friday, September, 20, 2024 ACTU Chart by TradingView Actuate Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/20/2024$8.19$7.31-10.74%$8.20$7.01109,771 shs$139.69 million09/19/2024$8.00$8.19+2.37%$8.19$8.004,560 shs$156.51 million09/18/2024$8.02$8.00-0.25%$8.23$8.0011,717 shs$152.88 million09/17/2024$8.37$8.02-4.18%$8.46$8.0039,921 shs$153.26 million09/16/2024$8.01$8.37+4.49%$8.37$7.8825,421 shs$159.95 million09/13/2024$7.95$8.01+0.75%$8.17$7.9520,594 shs$153.07 million Get the Latest News and Ratings for ACTU and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Actuate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/12/2024$8.08$7.95-1.61%$8.22$7.5099,736 shs$151.92 million09/11/2024$8.20$8.08-1.46%$8.40$8.0874,303 shs$154.41 million09/10/2024$8.27$8.20-0.85%$8.25$8.1032,516 shs$156.70 million09/09/2024$8.15$8.27+1.47%$8.47$7.9556,223 shs$158.04 million09/06/2024$8.15$8.15$8.20$7.9627,199 shs$155.75 million09/05/2024$8.19$8.15-0.49%$8.24$8.049,544 shs$155.75 million09/04/2024$8.02$8.19+2.12%$8.27$8.0523,187 shs$156.51 million09/03/2024$8.05$8.02-0.37%$8.20$7.985,756 shs$153.26 million09/02/2024$8.05$8.05$8.25$8.0038,400 shs$153.84 million08/30/2024$8.13$8.07-0.74%$8.25$8.0038,448 shs$0.0008/29/2024$7.98$8.13+1.88%$8.17$7.9111,742 shs$0.0008/28/2024$8.05$7.98-0.87%$8.20$7.9827,618 shs$0.0008/27/2024$7.96$8.05+1.13%$8.20$8.0314,061 shs$0.0008/26/2024$8.08$7.96-1.49%$8.50$7.96185,433 shs$0.0008/23/2024$8.05$8.08+0.37%$8.15$8.0010,124 shs$0.0008/22/2024$8.60$8.05-6.40%$8.78$8.0532,476 shs$0.0008/21/2024$8.46$8.60+1.65%$8.95$8.3321,687 shs$0.0008/20/2024$8.79$8.46-3.75%$8.99$7.9731,176 shs$0.0008/19/2024$8.70$8.79+1.03%$9.00$8.0636,342 shs$0.0008/16/2024$8.90$8.70-2.22%$9.21$8.0641,551 shs$0.0008/15/2024$9.15$8.90-2.76%$10.16$7.3349,588 shs$0.0008/14/2024$8.61$9.15+6.27%$9.45$8.6158,985 shs$0.0008/13/2024N/A$8.61$9.88$7.5091,711 shs$0.00 Related Companies: RGNX Stock Chart YMAB Stock Chart ATXS Stock Chart VECT Stock Chart SIGA Stock Chart APLT Stock Chart SLN Stock Chart CRBP Stock Chart PROK Stock Chart QTTB Stock Chart Receive ACTU Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actuate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACTU) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredThe Perfect Storm for an EV RevoltWith constant talk about Artifical Intelligence, inflation, and the upcoming election clogging the airwaves......Eagle Publishing | SponsoredTrump’s “Tax Free” Retirement StrategySince 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on re...Gold Safe Exchange | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actuate Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Actuate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
